| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
FinCanna Capital Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0024 |
| 52 Week High | CA$0.0085 |
| 52 Week Low | CA$0.001 |
| Beta | 1.62 |
| 1 Month Change | 4.26% |
| 3 Month Change | 11.36% |
| 1 Year Change | -38.75% |
| 3 Year Change | -99.65% |
| 5 Year Change | -99.73% |
| Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| FNNZ.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 63.3% | 1.4% | 2.7% |
| 1Y | -38.8% | 12.9% | 26.0% |
Return vs Industry: FNNZ.F underperformed the US Pharmaceuticals industry which returned 12% over the past year.
Return vs Market: FNNZ.F underperformed the US Market which returned 25% over the past year.
Price Volatility
| FNNZ.F volatility | |
|---|---|
| FNNZ.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FNNZ.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine FNNZ.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Vern Vipul | n/a |
FinCanna Capital Corp. does not have significant operations. Previously, it provided financing for companies operating in the cannabis sector. FinCanna Capital Corp. is headquartered in Vancouver, Canada.
FinCanna Capital Corp. Fundamentals Summary
| FNNZ.F fundamental statistics | |
|---|---|
| Market cap | US$3.64m |
| Earnings (TTM) | -US$302.56k |
| Revenue (TTM) | n/a |
-9.2x
P/S Ratio-12.0x
P/E RatioIs FNNZ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FNNZ.F income statement (TTM) | |
|---|---|
| Revenue | -CA$542.23k |
| Cost of Revenue | CA$0 |
| Gross Profit | -CA$542.23k |
| Other Expenses | -CA$127.96k |
| Earnings | -CA$414.27k |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00042 |
| Gross Margin | 100.00% |
| Net Profit Margin | 76.40% |
| Debt/Equity Ratio | -95.8% |
How did FNNZ.F perform over the long term?
See historical performance and comparison